Literature DB >> 33772301

Eighth Kraepelin Symposium-Translation in Psychiatry and Psychotherapy: A Life-Long Necessity.

Schaub Annette1, Falkai Peter1.   

Abstract

Entities:  

Keywords:  affective disorders; cognitive behavior therapy; cognitive dysfunction; cognitive psychoeducational therapy; cognitive remediation; early recognition; illness management; machine learning; mindfulness; schizophrenia

Mesh：

Year:  2021        PMID： 33772301      PMCID： PMC8084421          DOI： 10.1093/schbul/sbab020

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN： 0586-7614            Impact factor:   9.306


× No keyword cloud information.
  22 in total

1.  Drug and family therapy in the aftercare of acute schizophrenics.

Authors:  M J Goldstein; E H Rodnick; J R Evans; P R May; M R Steinberg
Journal:  Arch Gen Psychiatry       Date:  1978-10

2.  Rising to the challenge of first episode psychosis: the NIMH Recovery After Initial Schizophrenia Episode (RAISE) initiative.

Authors:  Kim T Mueser; Judith A Cook
Journal:  Psychiatr Rehabil J       Date:  2014-12

3.  Neural correlates of individual differences in affective benefit of real-life urban green space exposure.

Authors:  Heike Tost; Markus Reichert; Urs Braun; Iris Reinhard; Robin Peters; Sven Lautenbach; Andreas Hoell; Emanuel Schwarz; Ulrich Ebner-Priemer; Alexander Zipf; Andreas Meyer-Lindenberg
Journal:  Nat Neurosci       Date:  2019-07-29       Impact factor: 24.884

4.  Primary psychosis: more to know, much more to do.

Authors:  William T Carpenter
Journal:  World Psychiatry       Date:  2021-02       Impact factor: 49.548

5.  Comprehensive Versus Usual Community Care for First-Episode Psychosis: 2-Year Outcomes From the NIMH RAISE Early Treatment Program.

Authors:  John M Kane; Delbert G Robinson; Nina R Schooler; Kim T Mueser; David L Penn; Robert A Rosenheck; Jean Addington; Mary F Brunette; Christoph U Correll; Sue E Estroff; Patricia Marcy; James Robinson; Piper S Meyer-Kalos; Jennifer D Gottlieb; Shirley M Glynn; David W Lynde; Ronny Pipes; Benji T Kurian; Alexander L Miller; Susan T Azrin; Amy B Goldstein; Joanne B Severe; Haiqun Lin; Kyaw J Sint; Majnu John; Robert K Heinssen
Journal:  Am J Psychiatry       Date:  2015-10-20       Impact factor: 18.112

6.  Are Randomized Controlled Trials on Pharmacotherapy and Psychotherapy for Positive Symptoms of Schizophrenia Comparable? A Systematic Review of Patient and Study Characteristics.

Authors:  Irene Bighelli; Claudia Leucht; Maximilian Huhn; Cornelia Reitmeir; Felicitas Schwermann; Sofia Wallis; John M Davis; Stefan Leucht
Journal:  Schizophr Bull       Date:  2020-04-10       Impact factor: 9.306

Review 7.  Meta-analysis of psychological treatments for posttraumatic stress disorder in adult survivors of childhood abuse.

Authors:  Thomas Ehring; Renate Welboren; Nexhmedin Morina; Jelte M Wicherts; Janina Freitag; Paul M G Emmelkamp
Journal:  Clin Psychol Rev       Date:  2014-10-24

8.  Feasibility and Preliminary Effects of Implementing Acceptance and Commitment Therapy for Inpatients With Psychotic-Spectrum Disorders in a Clinical Psychiatric Intensive Care Setting.

Authors:  Brandon A Gaudiano; Stacy Ellenberg; Barbara Ostrove; Jennifer Johnson; Kim T Mueser; Martin Furman; Ivan W Miller
Journal:  J Cogn Psychother       Date:  2020-01-01

9.  AVATAR therapy for auditory verbal hallucinations in people with psychosis: a single-blind, randomised controlled trial.

Authors:  Tom Kj Craig; Mar Rus-Calafell; Thomas Ward; Julian P Leff; Mark Huckvale; Elizabeth Howarth; Richard Emsley; Philippa A Garety
Journal:  Lancet Psychiatry       Date:  2017-11-23       Impact factor: 27.083

Review 10.  [Psychosocial support during the COVID-19 pandemic: interdisciplinary concept of care at a university hospital].

Authors:  Matthias A Reinhard; Gerrit Burkhardt; Fabienne Grosse-Wentrup; Daniela Eser-Valerie; Friederike H A Mumm; Bernhard Barnikol-Oettler; Claudia Bausewein; Michael von Bergwelt-Baildon; Matthias Klein; Peter Falkai; Karl-Walter Jauch; Kristina Adorjan; Frank Padberg; Eva Hoch
Journal:  Nervenarzt       Date:  2020-10-06       Impact factor: 1.214
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.